kamata yasuyuki

FacultyInternalMedicineRheumatology&ClinicalImmunology
Job titleAssistant ProfessorWeb site

Profile

Research Areas

  • Clinical internal medicine / Collagenous pathology/Allergology

Academic Societies

  • JAPAN COLLEGE OF RHEUMATOLOGY
  • JAPANESE SOCIETY OF ALLERGOLOGY
  • THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY
  • THE JAPANESE SOCIETY OF INTERNAL MEDICINE
Display all
Academic Societiesclose
  • JAPAN COLLEGE OF RHEUMATOLOGY
  • JAPANESE SOCIETY OF ALLERGOLOGY
  • THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY
  • THE JAPANESE SOCIETY OF INTERNAL MEDICINE

Research Activities

Papers(paper)

  • Successful treatment of a patient with SAPHO syndrome with certolizumab pegol.
    Kamata Y, Minota S
    Rheumatology international Apr. 2015
  • No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis.
    Kamata Y, Minota S
    European journal of internal medicine Mar. 2015
  • Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon.
    Kamata Y, Minota S
    Rheumatology international May 2014
  • Three-pointed star sign of lupus enteritis.
    Kamata Y, Minota S
    Rheumatology (Oxford, England) 52 1008 Jun. 2013
  • An unusual cause of hemichorea-hemiballism in a patient with systemic lupus erythematosus.
    Maruyama A, Nagashima T, Kamata Y, Nagatani K, Murosaki T, Yoshio T, Minota S
    Rheumatology international 33 267-268 Jan. 2013
  • Successful treatment of massive intractable pericardial effusion in a patient with systemic lupus erythematosus with tocilizumab.
    Kamata Y, Minota S
    BMJ case reports 2012 Dec. 2012
  • Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season.
    Iwamoto M, Homma S, Onishi S, Kamata Y, Nagatani K, Yamagata Z, Minota S
    Rheumatology international 32 3691-3694 Nov. 2012
  • Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
    Nagashima T, Okazaki H, Kamata Y, Minota S
    Modern rheumatology / the Japan Rheumatism Association 22 638-9; authoe reply 640 Aug. 2012
  • Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection.
    Nagashima T, Maruyama A, Kamata Y, Minota S
    Rheumatology international 32 2231-2232 Jul. 2012
  • Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response.
    Matsuyama Y, Okazaki H, Hoshino M, Onishi S, Kamata Y, Nagatani K, Nagashima T, Iwamoto M, Yoshio T, Ohto-Ozaki H, Tamemoto H, Komine M, Sekiya H, Tominaga S, Minota S
    Rheumatology international 32 1397-1401 May 2012
Display all
Papers(paper)close
  • Successful treatment of a patient with SAPHO syndrome with certolizumab pegol.
    Kamata Y, Minota S
    Rheumatology international Apr. 2015
  • No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis.
    Kamata Y, Minota S
    European journal of internal medicine Mar. 2015
  • Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon.
    Kamata Y, Minota S
    Rheumatology international May 2014
  • Three-pointed star sign of lupus enteritis.
    Kamata Y, Minota S
    Rheumatology (Oxford, England) 52 1008 Jun. 2013
  • An unusual cause of hemichorea-hemiballism in a patient with systemic lupus erythematosus.
    Maruyama A, Nagashima T, Kamata Y, Nagatani K, Murosaki T, Yoshio T, Minota S
    Rheumatology international 33 267-268 Jan. 2013
  • Successful treatment of massive intractable pericardial effusion in a patient with systemic lupus erythematosus with tocilizumab.
    Kamata Y, Minota S
    BMJ case reports 2012 Dec. 2012
  • Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season.
    Iwamoto M, Homma S, Onishi S, Kamata Y, Nagatani K, Yamagata Z, Minota S
    Rheumatology international 32 3691-3694 Nov. 2012
  • Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al.
    Nagashima T, Okazaki H, Kamata Y, Minota S
    Modern rheumatology / the Japan Rheumatism Association 22 638-9; authoe reply 640 Aug. 2012
  • Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection.
    Nagashima T, Maruyama A, Kamata Y, Minota S
    Rheumatology international 32 2231-2232 Jul. 2012
  • Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response.
    Matsuyama Y, Okazaki H, Hoshino M, Onishi S, Kamata Y, Nagatani K, Nagashima T, Iwamoto M, Yoshio T, Ohto-Ozaki H, Tamemoto H, Komine M, Sekiya H, Tominaga S, Minota S
    Rheumatology international 32 1397-1401 May 2012
  • Healthcare-associated infections in rheumatology in Japan.
    Iwamoto M, Kamimura T, Nagashima T, Kamata Y, Aoki Y, Onishi S, Minota S
    Rheumatology international 32 801-804 Mar. 2012
  • Progressive multicentric reticulohistiocytosis.
    Kamata Y, Minota S
    Internal medicine 51 687-688 2012
  • Multiple Arterial Microaneurysms in Polyarteritis Nodosa
    Kamata Y, Seiji M
    BMJ 343 d6854 Oct. 2011
  • Repeated local implantation of autologous peripheral blood mononuclear cells for the treatment of ischaemic digits in patients with connective tissue diseases.
    Kamata Y, Iwamoto M, Muroi K, Minota S
    Rheumatology (Oxford, England) 50 906-910 May 2011
  • Successful treatment of a patient with rheumatoid arthritis and IgA-κ multiple myeloma with tocilizumab.
    Matsuyama Y, Nagashima T, Honne K, Kamata Y, Iwamoto M, Okazaki H, Sato K, Ozawa K, Minota S
    Internal medicine 50 639-642 2011
  • Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.
    Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, Nagashima T, Hayakawa M, Iwamoto M, Yoshio T, Tominaga S, Minota S
    The Journal of rheumatology 37 18-25 Jan. 2010
  • Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept.
    Takatori S, Kamata Y, Murosaki T, Iwamoto M, Minota S
    The Journal of rheumatology 37 210-211 Jan. 2010
  • Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases.
    Aoki Y, Iwamoto M, Kamata Y, Nagashima T, Yoshio T, Okazaki H, Minota S
    Rheumatology international 29 1327-1330 Sep. 2009
  • Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome?
    Nagashima T, Onishi S, Kamata Y, Minota S
    Rheumatology international 29 1261-1262 Aug. 2009
  • Treatment of rheumatoid arthritis with tacrolimus: tacrolimus-induced urticaria.
    Kamata Y, Iwamoto M, Minota S
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 15 213 Jun. 2009
  • [Treatment of pulmonary hypertension associated with connective tissue disease].
    Kamata Y, Iwamoto M, Minota S
    Japanese journal of clinical immunology 31 424-431 Dec. 2008
  • Urinary beta2-microglobulin as a sensitive marker for haemophagocytic syndrome associated with collagen vascular diseases.
    Onishi S, Ikenoya K, Matsumoto K, Kamata Y, Nagashima T, Kamimura T, Iwamoto M, Minota S
    Rheumatology (Oxford, England) 47 1730-1732 Nov. 2008
  • Massive intractable pericardial effusion in a patient with systemic lupus erythematosus treated successfully with pericardial fenestration alone.
    Kamata Y, Iwamoto M, Aoki Y, Kishaba Y, Nagashima T, Nara H, Kamimura T, Tanaka A, Yoshio T, Okazaki H, Minota S
    Lupus 17 1033-1035 Nov. 2008
  • Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T, Nara H, Iwamoto M, Yoshio T, Okazaki H, Minota S
    The Journal of rheumatology 35 936-938 May 2008
  • Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases.
    Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, Muroi K, Ikeda U, Shimada K, Yoshio T, Okazaki H, Minota S
    Rheumatology (Oxford, England) 46 882-884 May 2007
  • Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controller.
    Kamata Y, Iwamoto M, Minota S
    Lupus 16 901-903 2007
  • Deep vein thrombosis in inpatients
    Kamata Y, Iwamoto M, Aoki Y, Nagashima T, Nara H, Kamimura T, Yoshio T, Okazaki H, Minota S
    Jichi Medical University journal 29 163-167 Dec. 2006
  • A case of rheumatoid arthritis with protein losing enteropathy induced by multiple diaphragmatic strictures of the small intestine: successful treatment by bougieing under double-balloon enteroscopy.
    Kamata Y, Iwamoto M, Nara H, Kamimura T, Takayashiki N, Yamamoto H, Sugano K, Yoshio T, Okazaki H, Minota S
    Gut 55 1372 Sep. 2006
  • Repeated massive tongue swelling due to the combined use of estramustine phosphate and angiotensin-converting enzyme inhibitor.
    Kamata Y, Iwamoto M, Kamimura T, Kanashiki E, Yoshio T, Okazaki H, Morita T, Minota S
    Journal of investigational allergology & clinical immunology 16 388-390 2006
  • Effect of steroid pulse therapy on mixed connective tissue disease with pulmonary arterial hypertension.
    Kamata Y, Nara H, Sato H, Masuyama JI, Minota S, Yoshio T
    Annals of the rheumatic diseases 64 1236-1237 Aug. 2005
  • Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis.
    Kamata Y, Kamimura T, Iwamoto M, Minota S
    Clinical and experimental dermatology 30 451 Jul. 2005
  • Striking fall of the arterial oxygen pressure induced by positional change in a case of systemic lupus erythematosus.
    Kamata Y, Kamimura T, Haneda K, Masuyama JI, Okazaki H, Minota S
    Lupus 14 641-642 2005
  • Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction.
    Kamata Y, Nara H, Kamimura T, Haneda K, Iwamoto M, Masuyama J, Okazaki H, Minota S
    Internal medicine (Tokyo, Japan) 43 1201-1204 Dec. 2004
  • Therapeutic results in patients with biphenotypic acute leukemia at Jichi Medical School Hospital
    Kamata Y, Nagashima T, Muroi K, Yamamoto C, Mori M, Miyazato A, Takatoku M, Nagai T, Otsuki T, Komatsu N, Ozawa K
    Jichi Medical School journal 26 9-13 Dec. 2003
  • [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report].
    Kamata Y, Kamimura T, Yoshio T, Hirata D, Masuyama J, Isoda N, Kanai N, Minota S
    Ryumachi. [Rheumatism] 43 667-671 Oct. 2003


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.